Hanlim Pharm Overview

  • Year Founded
  • 1974

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 1

Hanlim Pharm General Information

Description

Developer of pharmaceutical products intended to advance treatment supplies and contribute to national health improvement. The company offers a diverse portfolio addressing hypertension, complex dyslipidemia, and coronary artery revascularization, supported by long-term investment in research labs and advanced medicine development, enabling patients and healthcare systems to access innovative therapies, improve outcomes, and strengthen public health.

Contact Information

Website
www.hanlim.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 42, Seocho-daero 52-gil
  • Seocho-gu
  • Seoul
  • South Korea
+82
Primary Industry
Pharmaceuticals
Corporate Office
  • 42, Seocho-daero 52-gil
  • Seocho-gu
  • Seoul
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hanlim Pharm Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 18-May-2026 Completed Generating Revenue
To view Hanlim Pharm’s complete valuation and funding history, request access »

Hanlim Pharm Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
LINK-J Accelerator/Incubator
To view Hanlim Pharm’s complete investors history, request access »

Hanlim Pharm Investments (7)

Hanlim Pharm’s most recent deal was a Seed Round with Mediconnector for . The deal was made on 30-Dec-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Mediconnector 30-Dec-2025 Seed Round Medical Supplies
Dr.inB 18-Jan-2024 Later Stage VC Other Devices and Supplies
RudaCure 30-May-2023 Later Stage VC Pharmaceuticals
Dr.inB 14-Jul-2022 Early Stage VC Other Devices and Supplies
QuadMedicine 09-May-2022 Later Stage VC Drug Delivery
You’re viewing 5 of 7 investments. Get the full list »

Hanlim Pharm FAQs

  • When was Hanlim Pharm founded?

    Hanlim Pharm was founded in 1974.

  • Where is Hanlim Pharm headquartered?

    Hanlim Pharm is headquartered in Seoul, South Korea.

  • What industry is Hanlim Pharm in?

    Hanlim Pharm’s primary industry is Pharmaceuticals.

  • Is Hanlim Pharm a private or public company?

    Hanlim Pharm is a Private company.

  • What is Hanlim Pharm’s current revenue?

    The current revenue for Hanlim Pharm is .

  • Who are Hanlim Pharm’s investors?

    LINK-J has invested in Hanlim Pharm.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process